#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anaplastic large cell lymphoma T- and null-cell types Arteriovenous malformation Haemophilia A with anti factor VIII Follicular lymphoma stage I Chronic cutaneous lupus erythematosus Atopic keratoconjunctivitis Diffuse large B-cell lymphoma recurrent Pseudomyxoma peritonei Glomerulonephritis membranous Non-small cell lung cancer Malignant oligodendroglioma Stress cardiomyopathy Familial hypertriglyceridaemia Lymphangioma Advanced systemic mastocytosis More trials…

    Learn about Rare Diseases

    Progressive supranuclear palsy – Trials in Disease VEXAS syndrome – Life with Disease Retinoblastoma – Treatment Fabry’s disease – Diagnostics Fragile X syndrome – Treatment Pituitary-dependent Cushing’s syndrome – Life with Disease Activated PI3 kinase delta syndrome – Life with Disease Cystic fibrosis Biotinidase deficiency – Life with Disease Mucous membrane pemphigoid – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Valganciclovir Levocarnitine Dyp688 Bay 3283142 GSK5458514 Sildenafil Citrate Vx-264 Peboctocogene Camaparvovec Imipenem Cilazapril Thiopental Sodium ADCE-D01 Gskvx000000008885 Bilastine Lixisenatide Eo2318 Nilutamide Cilastatin Sodium SEVABERTINIB Fluticasone Propionate More therapies…

    Learn about Your Condition

    Enteritis Vestibular disorder Systemic scleroderma Amnestic disorder Venous thrombosis limb Bacterial vaginosis Thrombectomy Fracture infection Hereditary optic atrophy Testicular germ cell cancer Chronic disease Habitual abortion Intermittent claudication Varicella Supranuclear palsy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Neoplasm malignant

  • Zongertinib for Cancer in Patients Eligible for Early Access Treatment

    Recruiting

    2 1 1
    Investigated Drugs:
    • Zongertinib
    Finland

  • A study of PM54 and pembrolizumab in adults with advanced cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Pembrolizumab
    Italy Spain

  • A study of S-241656 and a drug combination in patients with certain types of cancer involving KRAS, BRAF, or other RAS/MAPK mutations

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • S-241656
    • Panitumumab
    • Cetuximab
    Denmark France Italy Spain

  • Phase 1/2A Study of OTP-01 to Evaluate Safety and Anti‑Tumor Activity in Patients with Advanced Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm malignant
    • Neoplasm
    Ireland Portugal Spain

  • A study of YL201 and atezolizumab for patients with advanced solid tumors

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • YL201
    • Atezolizumab
    Belgium France Germany Hungary Italy Poland +2

  • A study of DS-3790A, rituximab, and epcoritamab in patients with blood cancers

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Epcoritamab
    • Rituximab
    France Italy
1 2 3 … 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!